Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/97185FD5.svg?ark=w1%2F20260515%2F97185FD5)](https://nobleid.org/work/w1/20260515/97185FD5)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors